Skip to main content
Clinical Trials/NCT03719625
NCT03719625
Unknown
Phase 4

Norepinephrine Versus Ephedrin for Prevention of Post Spinal Anesthesia in Cesarean Section

Mongi Slim Hospital0 sites200 target enrollmentJanuary 2, 2019

Overview

Phase
Phase 4
Intervention
Norepinephrine
Conditions
Maternal Hypotension Syndrome
Sponsor
Mongi Slim Hospital
Enrollment
200
Primary Endpoint
Incidence of post spinal hypotension
Last Updated
7 years ago

Overview

Brief Summary

Spinal anesthesia is still the gold standard anesthetic method for elective and urgent cesarean section, the post spinal hypotension remains the most frequent complication of this procedure and is still responsible of considerable maternel and fetal morbidity. It is recommanded to prevent this post spinal hypotension with fluid coloading and prophylactic vasopressors administration.

The aim of this study is to compare the efficency and the safety of norepinephrin and ephedrin prophylactic administration to reduce the incidence of post spinal hypotension in cesarean section.

Detailed Description

Spinal anesthesia is still the gold standard anesthetic method for elective and urgent cesarean section, the post spinal hypotension remains the most frequent complication of this procedure and is still responsible of considerable maternel and fetal morbidity. It is recommanded to prevent this post spinal hypotension with fluid coloading and prophylactic vasopressors administration. The prophylactic use of norepinephrin and phenylephrin has been validated by several studies, but few data are published concerning the comparaison between norepinephrin and ephedrine as preventive vasopressors in cesarean section; these molecules act on alpha and beta adrenergic receptors and could provide better maternal hemodynamics in parturients undergoing cesarean section under spinal anesthesia. The aim of this study is to compare the efficency and the safety of norepinephrin and ephedrin prophylactic administration to reduce the incidence of post spinal hypotension in cesarean section.

Registry
clinicaltrials.gov
Start Date
January 2, 2019
End Date
May 30, 2019
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mhamed Sami Mebazaa

Head of the anesthesia intensive care department

Mongi Slim Hospital

Eligibility Criteria

Inclusion Criteria

  • full termed parturients scheduled for elective or semi urgent cesarean section under spinal anesthesia
  • AGE\>15 years
  • ASA II status
  • No history of hypertension, preeclampsia or cardiopathy

Exclusion Criteria

  • cesarean section under genearl anesthesia or epidural analgesia during labor

Arms & Interventions

norepinephrin group

The patients of this group will recieve 0.5 micro gr/kg of norepinephin intravenously, the infusion will start during the intrathecal injection and during 10 minutes

Intervention: Norepinephrine

Ephedrin group

The patients of this group will recieve 0,3mg/kg of Ephedrin intravenously, the infusion will start during the intrathecal injection and during 10 minutes

Intervention: Ephedrine

Outcomes

Primary Outcomes

Incidence of post spinal hypotension

Time Frame: during the first 20 minutes after spinal anesthesia

decrease of systolic arterial blood pressure \> 20% baseline

Secondary Outcomes

  • Lowest systolic blood pressure(uring the first 20 minutes after spinal anesthesia)
  • Incidence of bradycardia(during the first 20 minutes after spinal anesthesia)
  • incidence of nausea and/or vomiting(during the first 20 minutes after spinal anesthesia)
  • Apgar score(20min after spinal anesthesia)
  • fetal ph(20min after spinal anesthesia)
  • fetal blood lactates(20min after spinal anesthesia)

Similar Trials